HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: Implications for intervention

Abel, 2004 Abel, 2005 Abel-Ollo, K., Talu, A., Vals K., Vorobjov, S., Paimre, M., Ahven, A., et al. (2007). National Report (2006 data) to the EMCDDA by the REITOX National Focal Point. Estonia. New developments and trends and in-depth information on selected issues. Retrieved October 31, 2008, from http://eusk.tai.ee/failid/ESTONIA_2007_NATIONAL_REPORTING_Final.pdf. Atlani, 2000, Social change and HIV in the former USSR: The making of a new epidemic, Social Science & Medicine, 50, 1547, 10.1016/S0277-9536(99)00464-5 Ball, 2007, HIV, injecting drug use and harm reduction: A public health response, Addiction, 102, 684, 10.1111/j.1360-0443.2007.01761.x Berens, 1996, Illicit fentanyl in Europe, Lancet, 347, 1334, 10.1016/S0140-6736(96)90981-2 Braine, 2005, HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs, AIDS Education and Prevention, 17, 515, 10.1521/aeap.2005.17.6.515 Booth, 2008, Stimulant injectors in Ukraine: The next wave of the epidemic, AIDS and Behavior, 12, 652, 10.1007/s10461-008-9359-3 Chaisson, 1989, Cocaine use and HIV infection in intravenous drug users in San Francisco, JAMA, 261, 561, 10.1001/jama.1989.03420040099027 Cicero, 2005, Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004, Journal of Pain, 6, 662, 10.1016/j.jpain.2005.05.004 Colfax, 2005, The methamphetamine epidemic: Implications for HIV prevention and treatment, Current HIV/AIDS Reports, 2, 194, 10.1007/s11904-005-0016-4 Connell, 1993, Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine, Journal of Medical Virology, 41, 159, 10.1002/jmv.1890410212 Darke, 1998, Self-report among injecting drug users: A review, Drug and Alcohol Dependence, 51, 253, 10.1016/S0376-8716(98)00028-3 Dehne, 1999, The HIV/AIDS epidemic in Eastern Europe: Recent patterns and trends and their implication for policy-making, AIDS, 13, 741, 10.1097/00002030-199905070-00002 Denton, 2008, An epidemic of illicit fentanyl deaths in Cook Country, Illinois: September 2005–April 2007, Journal of Forensic Sciences, 53, 452, 10.1111/j.1556-4029.2008.00669.x Des Jarlais, 1994, Reliability and validity in cross-national research on AIDS risk behavior among injecting drug users. HIV epidemiology: Models and methods, 65 European Monitoring Centre for Drugs and Drug Addiction (2004). Annual report 2004: the state of the drugs problem in the European Union and Norway. Luxembourg. European Monitoring Centre for Drugs and Drug Addiction. (2006). Annual report 2006: the state of the drugs problem in Europe. Luxembourg. European Centre for the Epidemiological Monitoring of HIV and AIDS. (2007). HIV/AIDS surveillance in Europe. End-year report 2006, 75. Retrieved, October 31, 2008, from http://www.eurohiv.org/reports/report_75/pdf/report_eurohiv_75.pdf. Fuller, 2003, Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users, Journal of Acquired Immune Deficiency Syndromes, 32, 86, 10.1097/00126334-200301010-00013 Hagan, 2000, HIV and HCV Infection among Injecting Drug Users, Mount Sinai Journal of Medicine, 67, 423 Hagan, 2005, HIV/hepatitis C virus co-infection in drug users: Risk behaviour and prevention, AIDS, 19, 199, 10.1097/01.aids.0000192090.61753.d4 Hamers, 2003, HIV in Central and Eastern Europe, Lancet, 361, 1035, 10.1016/S0140-6736(03)12831-0 Heckathorn, 1997, Respondent-driven sampling: A new approach to the study of hidden populations, Social Problems, 44, 174, 10.2307/3096941 Heckathorn, 2002, Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations, Social Problems, 49, 11, 10.1525/sp.2002.49.1.11 Heckathorn, 2006 Henderson, 1991, Fentanyl-related deaths: Demographics, circumstances, and toxicology of 112 cases, Journal of Forensic Sciences, 36, 422, 10.1520/JFS13045J Hien, 2001, Risk factors of HIV infection and needle sharing among injecting drug users in Ho Chi Minh City, Vietnam, Journal of Substance Abuse, 13, 45, 10.1016/S0899-3289(01)00059-1 Hull, 2007, Fatalities associated with fentanyl and co-administered cocaine or opiates, Journal of Forensic Science, 52, 1383 Jönsson, 2007, Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002–2003, Forensic Science International, 169, 101, 10.1016/j.forsciint.2006.08.002 Kelly, 2003, The newest epidemic: A review of HIV/AIDS in Central and Eastern Europe, International Journal of STD & AIDS, 14, 361, 10.1258/095646203765371231 Kronstrand, 1997, Cluster of fentanyl-related deaths among drug addicts in Sweden, Forensic Science International, 88, 185, 10.1016/S0379-0738(97)00068-6 Lõhmus, L., & Trummal, A. (2007). Süstlavahetusteenuse külastajate HIV/AIDS-iga seotud riskikäitumine ja teadmised. Esmas- ja korduvklientide võrdlev analüüs 2006. Tervise Arengu Instituut, Tallinn [Risk behaviour related with HIV/AIDS of the visitors of syringe exchange services. Comparative analysis of primary and repeated visitors, National institute for Health Development, Tallinn]. Retrieved October 3, 2008, from http://www2.tai.ee/teated/GF/Systlavahetuse_kylastajad_2006.pdf. Magis-Rodríguez, 2005, HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana, Journal of Psychoactive Drugs, 37, 333, 10.1080/02791072.2005.10400528 Marks, 2005, Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected With HIV in the United States: Implications for HIV prevention programs, Journal of Acquired Immune Deficiency Syndromes, 39, 446, 10.1097/01.qai.0000151079.33935.79 Molitor, 1999, Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users, American Journal of Drug and Alcohol Abuse, 25, 475, 10.1081/ADA-100101874 Molitor, 1998, Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users, Western Journal of Medicine, 168, 93 Ojanperä, 2006, Blood levels of 3-methylfentanyl in 3 fatal poisoning cases, American Journal of Forensic Medicine and Pathology, 27, 328, 10.1097/01.paf.0000188097.78132.e5 Ojanperä, 2008, An epidemic of fatal 3-methylfentanyl poisoning in Estonia, International Journal of Legal Medicine, 122, 395, 10.1007/s00414-008-0230-x Oole, K., Talu, A., Vals, K., Paimre, M., Ahven, A., & Neuman, A., et al. (2006). National Report (2005 data) to the EMCDDA by the REITOX National Focal Point. Estonia. New developments and trends and in-depth information on selected issues. 2006. Retrieved October, 31, 2008, from http://eusk.tai.ee/failid/Report_Drug_situation_in_Estonia_2006.pdf. Parry, 1995, GACPAT HIV 1+2: A simple, inexpensive assay to screen for, and discriminate between, anti-HIV 1 and anti-HIV 2, Journal of Medical Virology, 45, 10, 10.1002/jmv.1890450103 Platt, 2006, High HIV prevalence of HIV among injecting drug users in Estonia: Implication for understanding the risk environment, AIDS, 20, 2103 Politseiamet (2005). Narkosüüteod ja nende mõju kuritegevusele Eestis 1999–2004. Tallinn. [Police Board (2005). Drug-related crime and its impact to crime in Estonia 1999–2004. Tallinn]. Retrieved October 31, 2008 from http://www.pol.ee/failid/Narko_analyys_internet.pdf. Pollini, 2008, Syringe possession arrests are associated with receptive syringe sharing in two Mexico–US border cities, Addiction, 103, 101, 10.1111/j.1360-0443.2007.02051.x Riiklik tervishoiuprogramm, 2005, Eesti riiklik HIV ja AIDSi strateegia aastateks 2006–2015 [National health care programme Estonian national HIV and AIDS strategy for the year 2006–2015], Riigi Teataja, 117, 1856 Rhodes, 2002, Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia, AIDS, 16, F25, 10.1097/00002030-200209060-00002 Rhodes, 2003, Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment, Social Science & Medicine, 57, 39, 10.1016/S0277-9536(02)00521-X Rhodes, 2004, Injecting equipment sharing among injecting drug users in Togliatti city, Russian Federation: Maximizing the protective effects of syringe distribution, Journal of Acquired Immune Deficiency Syndromes, 35, 293, 10.1097/00126334-200403010-00011 Rhodes, 2005, The social production of HIV risk among injecting drug users, Social Science & Medicine, 61, 1026, 10.1016/j.socscimed.2004.12.024 Rosenblum, 2007, Prescription opioid abuse among enrollees into methadone maintenance treatment, Drug and Alcohol Dependence, 90, 64, 10.1016/j.drugalcdep.2007.02.012 Talu, 2003 Talu, A., Abel-Ollo, K., Vals, K., & Ahven, A. (2008). 2008 National Report (2007 data) to the EMCDDA by the Reitox National Focal Point. “Estonia”. New Development, trends and in-depth information on selected issues. Retrieved January 20, 2009, from http://eusk.tai.ee/failid/report_2008_english_ESTONIAN.pdf. Tyndall, 2003, Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic, AIDS, 17, 887, 10.1097/00002030-200304110-00014 UNAIDS/WHO. (2006). AIDS epidemic update: December 2006. Retrieved October 31, 2008, from http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2006/Default.asp. UNODC. World drug report. (2005). Retrieved September 3, 2008, from http://www.unodc.org/pdf/WDR_2005/volume_1_web.pdf. Uusküla, 2006, Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an Estonian injection drug-using population: Sensitivity and specificity of testing syringes for public health surveillance, Journal of Infectious Diseases, 193, 455, 10.1086/499436 Uusküla, 2008, HIV infection among new injecting drug users in Estonia: Need for large scale prevention programes, Journal of Public Health (Oxford, England), 30, 119, 10.1093/pubmed/fdn014 Uusküla, 2007, High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia, International Journal of STD & AIDS, 18, 41, 10.1258/095646207779949907 Uusküla, 2007, Estimating injection drug use prevalence using state wide administrative data sources: Estonia 2004, Addiction Research and Theory, 15, 411, 10.1080/16066350701417533 Vallejo, 2004, Opioid therapy and immunosuppression: A review, American Journal of Therapeutics, 11, 354, 10.1097/01.mjt.0000132250.95650.85 Victora, 1997, The role of conceptual frameworks in epidemiological analysis: A hierarchical approach, International Journal of Epidemiology, 26, 224, 10.1093/ije/26.1.224 Wang, 2005, Respondent-driven sampling to recruit MDMA users: A methodological assessment, Drug and Alcohol Dependence, 78, 147, 10.1016/j.drugalcdep.2004.10.011 Wei, 2003, Opioid-induced immunosuppression: Is it centrally mediated or peripherally mediated?, Biochemical Pharmacology, 65, 1666, 10.1016/S0006-2952(03)00085-6 Werb, 2008, HIV risks associated with incarceration among injection drug users: Implications for prison-based public health strategies, Journal of Public Health (Oxford, England), 30, 126, 10.1093/pubmed/fdn021 Wilson, 2007, The HIV prevention needs of injection drug users in Estonia, International Journal of STD & AIDS, 18, 389, 10.1258/095646207781024900 Wong, 2008, Concurrent detection of heroin, fentanyl, and xylaxzine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office, Journal of Forensic Sciences, 53, 495, 10.1111/j.1556-4029.2007.00648.x Wood, 2005, Recent incarceration independently associated with syringe sharing by injection drug users, Public Health Reports, 120, 150, 10.1177/003335490512000208